Drug repurposing as a source of innovative therapies in osteosarcoma.
Sign Up to like & getrecommendations! Published in 2018 at "Journal of Clinical Oncology"
DOI: 10.1200/jco.2018.36.15_suppl.11524
Abstract: 11524Background: Chemotherapy and surgery achieve a 5-year event-free survival of 60-70% in localized osteosarcoma (OS), but little additional progress has been made in recent decades. Clinical res... read more here.
Keywords: drug repurposing; source innovative; oncology; therapies osteosarcoma ... See more keywords
Origin and Therapies of Osteosarcoma
Sign Up to like & getrecommendations! Published in 2022 at "Cancers"
DOI: 10.3390/cancers14143503
Abstract: Simple Summary Osteosarcoma is the most common malignant bone tumor in children, with a 5-year survival rate ranging from 70% to 20% depending on the aggressiveness of the disease. The current treatments have not evolved… read more here.
Keywords: survival; disease; diagnosis; origin therapies ... See more keywords